Novavax doubles down on promise to produce 2B Nuvaxovid doses — this year

If there’s one thing Novavax executives wanted to push across in the company’s 2021 Q4 earnings call Monday, it’s that, after months of struggles, it is in a position to manufacture 2 billion doses of its Covid-19 vaccine.